$4.68
0.21% today
Nasdaq, Apr 03, 06:34 pm CET
ISIN
US74019P1084
Symbol
DTIL
Sector
Industry

Precision BioSciences, Inc. Stock price

$4.69
-0.31 6.20% 1M
-4.46 48.74% 6M
+0.88 23.10% YTD
-9.51 66.97% 1Y
-95.51 95.32% 3Y
-161.51 97.18% 5Y
-475.31 99.02% 10Y
Nasdaq, Closing price Wed, Apr 02 2025
+0.20 4.45%
ISIN
US74019P1084
Symbol
DTIL
Sector
Industry

Key metrics

Market capitalization $19.06m
Enterprise Value $-37.20m
P/E (TTM) P/E ratio 2.48
EV/FCF (TTM) EV/FCF 0.61
EV/Sales (TTM) EV/Sales -0.54
P/S ratio (TTM) P/S ratio 0.28
P/B ratio (TTM) P/B ratio 0.68
Revenue growth (TTM) Revenue growth 40.98%
Revenue (TTM) Revenue $68.70m
EBIT (operating result TTM) EBIT $-26.16m
Free Cash Flow (TTM) Free Cash Flow $-60.69m
Cash position $86.31m
EPS (TTM) EPS $1.89
P/E forward negative
P/S forward 1.08
EV/Sales forward negative
Short interest 8.18%
Show more

Is Precision BioSciences, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Precision BioSciences, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

4 Analysts have issued a Precision BioSciences, Inc. forecast:

4x Buy
100%

Analyst Opinions

4 Analysts have issued a Precision BioSciences, Inc. forecast:

Buy
100%

Financial data from Precision BioSciences, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
69 69
41% 41%
100%
- Direct Costs 4.58 4.58
45% 45%
7%
64 64
58% 58%
93%
- Selling and Administrative Expenses 29 29
4% 4%
42%
- Research and Development Expense 57 57
17% 17%
83%
-22 -22
61% 61%
-31%
- Depreciation and Amortization 4.58 4.58
45% 45%
7%
EBIT (Operating Income) EBIT -26 -26
59% 59%
-38%
Net Profit 7.17 7.17
110% 110%
10%

In millions USD.

Don't miss a Thing! We will send you all news about Precision BioSciences, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Precision BioSciences, Inc. Stock News

Neutral
Business Wire
2 days ago
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene elimination, gene insertion, and gene excision programs, today announced that management will present at the 24th Annual Needham Virtual Healthcare Conference taking place on Apr...
Neutral
Business Wire
8 days ago
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for high unmet need diseases, today announced financial results for the fourth quarter and fiscal year ended December 31, 2024, and provided a business update. “2024 was a transformational year ...
Neutral
Business Wire
13 days ago
DURHAM, N.C.--(BUSINESS WIRE)--Precision BioSciences, Inc. (Nasdaq: DTIL), a clinical stage gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, including gene elimination, gene insertion, and gene excision programs, today announced that it will publish financial results for the fourth quarter and fiscal year 2024 and provide a business...
More Precision BioSciences, Inc. News

Company Profile

Precision BioSciences, Inc. is a biotechnology company, which engages in the development of genome editing technologies. It operates through the Therapeutics and Food segments. The Therapeutics segment focuses on the development of products in the field of immuno-oncology and of novel products outside immuno-oncology to treat human diseases. The Food segment applies ARCUS, the company's propriety genome editing platform, to develop food and nutrition products through collaboration agreements with consumer-facing companies. The company was founded by Derek N. Jantz, Jeff Smith, and Matthew R. Kane in January 2006 and is headquartered in Durham, NC.

Head office United States
CEO Michael Amoroso
Employees 108
Founded 2006
Website www.precisionbiosciences.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today